A novel immunostimulatory OX40/PD-L1 bivalent bispecific antibody (MEDI1109) for the treatment of patients with cancer

被引：2

作者：

Oberst, Michael D. ^{[1
]}

Kasturirangan, Srinath ^{[1
]}

Sachs, Clifford ^{[1
]}

Auge, Catherine ^{[1
]}

Moynihan, James ^{[1
]}

Rothstein, Raymond ^{[1
]}

Hair, James ^{[2
]}

Neal, Francis ^{[2
]}

Mamidi, Srinivas ^{[2
]}

Hanabuchi, Shino ^{[1
]}

Watkins, Amanda ^{[2
]}

Zheng, Yanan ^{[3
]}

Rosenthal, Kim ^{[1
]}

Freeman, Daniel J. ^{[1
]}

Hammond, Scott ^{[1
]}

机构：

[1] MedImmune, Gaithersburg, MD USA

[2] MedImmune, Liverpool, Merseyside, England

[3] MedImmune, San Francisco, CA USA

来源：

CANCER RESEARCH | 2018年 / 78卷 / 13期

关键词：

D O I：

10.1158/1538-7445.AM2018-2775

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2775

引用

页数：2

共 50 条

[21] Blockade of dual immune checkpoint inhibitory signals with a CD47/PD-L1 bispecific antibody for cancer treatment [J].

Wang, Rongjuan ;

Zhang, Chang ;

Cao, Yuting ;

Wang, Junchao ;

Jiao, Shasha ;

Zhang, Jiao ;

Wang, Min ;

Tang, Peipei ;

Ouyang, Zijun ;

Liang, Wenlu ;

Mao, Yu ;

Wang, An ;

Li, Gang ;

Zhang, Jinchao ;

Wang, Mingzhu ;

Wang, Shuang ;

Gui, Xun .

THERANOSTICS, 2023, 13 (01) :148-160

[22] 原发性干燥综合征患者外周血OX40、OX40L、PD-1、PD-L1和SPD-1的表达及临床意义 [J].

郑戈 ;

袁一梦 .

临床误诊误治, 2017, 30 (10) :83-87

[23] Development of a novel PD-L1xCD40 bispecific antibody with excellent efficacy and safety profile for cancer therapy [J].

Luo, Haishan ;

Meng, Zihong ;

Rong, Jimmy ;

Wang, Yuandong ;

Yang, Yunxing ;

Chen, Fei ;

Wang, Youhong ;

Chen, Victor ;

Deng, Gang ;

He, Yebo ;

Gan, Xin ;

Rong, Yiping .

CANCER RESEARCH, 2022, 82 (12)

[24] A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice [J].

Foote, Jeremy B. ;

Kok, Marleen ;

Leatherman, James M. ;

Armstrong, Todd D. ;

Marcinkowski, Bridget C. ;

Ojalvo, Laureen S. ;

Kanne, David B. ;

Jaffee, Elizabeth M. ;

Dubensky, Thomas W., Jr. ;

Emens, Leisha A. .

CANCER IMMUNOLOGY RESEARCH, 2017, 5 (06) :468-479

[25] Safety and efficacy of durvalumab (MEDI4736) a PD-L1 antibody, in urothelial bladder cancer. [J].

Massard, Christophe ;

Gordon, Michael S. ;

Sharma, Sunil ;

Rafii, Saeed ;

Wainberg, Zev A. ;

Luke, Jason John ;

Curiel, Tyler J. ;

Colon-Otero, Gerardo ;

Hamid, Omid ;

Sanborn, Rachel E. ;

O'Donnell, Peter H. ;

Drakaki, Alexandra ;

Kurland, John ;

Rebelatto, Marlon C. ;

Jin, Xiaoping ;

Blake-Haskins, John A. ;

Gupta, Ashok Kumar ;

Segal, Neil Howard .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)

[26] Optimising TNFRSF agonism and checkpoint blockade with a novel CD137/PD-L1 bispecific antibody [J].

Lakins, M. A. ;

Munoz-Olaya, J. ;

Jones, D. ;

Giambalvo, R. ;

Hall, C. ;

Knudsen, A. ;

Soler, N. Masque ;

Pechouckova, S. ;

Goodman, E. ;

Gradinaru, C. ;

Koers, A. ;

Marshall, S. ;

Wydro, M. ;

Wollerton, F. ;

Batey, S. ;

Gliddon, D. ;

Davies, M. ;

Morrow, M. ;

Tuna, M. ;

Brewis, N. .

ANNALS OF ONCOLOGY, 2018, 29

[27] A Phase 1 First-in-Human Study of FS118, a Tetravalent Bispecific Antibody Targeting LAG-3 and PD-L1 in Patients with Advanced Cancer and PD-L1 Resistance [J].

Yap, Timothy A. ;

LoRusso, Patricia M. ;

Wong, Deborah J. ;

Hu-Lieskovan, Siwen ;

Papadopoulos, Kyriakos P. ;

Holz, Josefin-Beate ;

Grabowska, Urszula ;

Gradinaru, Cristian ;

Leung, Kin-Mei ;

Marshall, Sylwia ;

Reader, Claire S. ;

Russell, Roslin ;

Sainson, Richard C. A. ;

Seal, Claire J. ;

Shepherd, Christopher J. ;

Germaschewski, Fiona ;

Gliddon, Daniel ;

Stern, Omer ;

Young, Lesley ;

Brewis, Neil ;

Kayitalire, Louis ;

Morrow, Michelle .

CLINICAL CANCER RESEARCH, 2023, 29 (05) :888-898

[28] A phase 1 study of CTX-8371, a bispecific PD-1/PD-L1 antibody, in patients with advanced malignancies Free [J].

Wang, Judy ;

Perez, Cesar A. ;

Ott, Patrick A. ;

Gandhi, Shipra ;

Araujo, Emilio ;

Warholic, Natalie ;

Sachsenmeier, Kris ;

Schuetz, Thomas ;

Rosales, Minori K. .

CANCER RESEARCH, 2025, 85 (08)

[29] Phase 1 study of MEDI0562, a humanized OX40 agonist monoclonal antibody (mAb), in adult patients (pts) with advanced solid tumors [J].

Glisson, B. S. ;

Leidner, R. ;

Ferris, R. L. ;

Powderly, J. ;

Rizvi, N. ;

Norton, J. D. ;

Burton, J. ;

Lanasa, M. C. ;

Patel, S. P. .

ANNALS OF ONCOLOGY, 2016, 27

[30] Prognostic Role of OX40, LAG-3, TIM-3 and PD-L1 Expression in Bone and Soft Tissue Sarcomas [J].

Inci, Bediz Kurt ;

Acar, Elif ;

Gurler, Fatih ;

Ilhan, Ayseguel ;

Yildiz, Fatih ;

Ardic, Fisun ;

Oksuzoglu, Berna ;

Ozdemir, Nuriye ;

Ozet, Ahmet ;

Esendagli, Guldal ;

Yazici, Ozan .

JOURNAL OF CLINICAL MEDICINE, 2024, 13 (12)

← 1 2 3 4 5 →